TSUI; Hon-Chung
Patent Applications and Registrations
Patent applications and USPTO patent grants for TSUI; Hon-Chung.The latest application filed is for "nk 1 antagonists".
Company Profile
0.24.31
- TSUI; Hon-Chung - East Brunswick NJ
- Tsui; Hon-Chung - Kenilworth NJ US
- Tsui; Hon-Chung - Shanghai CN
Patent Activity
| Patent | Date |
|---|---|
| Nk 1 Antagonists App 20180215729 - PALANI; Anandan ; et al. | 2018-08-02 |
| Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 10,000,493 - Mergelsberg , et al. June 19, 2 | 2018-06-19 |
| NK.sub.1 antagonists Grant 9,969,711 - Palani , et al. May 15, 2 | 2018-05-15 |
| Nk1 Antagonists App 20170283434 - Paliwal; Sunil ; et al. | 2017-10-05 |
| NK.sub.1 antagonists Grant 9,688,693 - Paliwal , et al. June 27, 2 | 2017-06-27 |
| Nk 1 Antagonists App 20170029403 - Palani; Anandan ; et al. | 2017-02-02 |
| Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20170008893 - Mergelsberg; Ingrid ; et al. | 2017-01-12 |
| NK.sub.1 antagonists Grant 9,469,629 - Palani , et al. October 18, 2 | 2016-10-18 |
| Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 9,260,428 - Mergelsberg , et al. February 16, 2 | 2016-02-16 |
| Nk1 Antagonists App 20140336158 - Paliwal; Sunil ; et al. | 2014-11-13 |
| Nk1 Antagonists App 20140296196 - Palani; Anandan ; et al. | 2014-10-02 |
| NK1 antagonists Grant 8,796,299 - Paliwal , et al. August 5, 2 | 2014-08-05 |
| NK1 antagonists Grant 8,754,216 - Shah , et al. June 17, 2 | 2014-06-17 |
| Compounds that are ERK inhibitors Grant 8,716,483 - Cooper , et al. May 6, 2 | 2014-05-06 |
| Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20140024834 - MERGELSBERG; Ingrid ; et al. | 2014-01-23 |
| N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 Grant 8,623,857 - Tsui , et al. January 7, 2 | 2014-01-07 |
| Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 8,552,191 - Mergelsberg , et al. October 8, 2 | 2013-10-08 |
| Compounds that are ERK inhibitors Grant 8,546,404 - Cooper , et al. October 1, 2 | 2013-10-01 |
| Novel Thiazol-Carboximide Derivatives as PDK1 Inhibitors App 20130165450 - Tsui; Hon-Chung ; et al. | 2013-06-27 |
| N-phenyl Imidazole Carboxamide Inhibitors Of 3-phosphoinositide-dependent Protein Kinase-1 App 20130079326 - Tsui; Hon-Chung ; et al. | 2013-03-28 |
| Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) App 20130053382 - Paliwal; Sunil ; et al. | 2013-02-28 |
| Nk1 Antagonists App 20130023503 - Paliwal; Sunil ; et al. | 2013-01-24 |
| NK1 Antagonists App 20120295879 - Palani; Anandan ; et al. | 2012-11-22 |
| NK.sub.1 antagonists Grant 8,273,895 - Paliwal , et al. September 25, 2 | 2012-09-25 |
| NK.sub.1 antagonists Grant 8,026,364 - Shah , et al. September 27, 2 | 2011-09-27 |
| Novel Compounds That Are Erk Inhibitors App 20110189192 - Cooper; Alan B. ; et al. | 2011-08-04 |
| Nk1 Antagonists App 20110098468 - Paliwal; Sunil ; et al. | 2011-04-28 |
| NK.sub.1 antagonists Grant 7,902,366 - Paliwal , et al. March 8, 2 | 2011-03-08 |
| Heterocyclic Compounds And Use Thereof As Erk Inhibitors App 20110038876 - Sun; Robert ; et al. | 2011-02-17 |
| Nk 1 Antagonists App 20100190759 - PALANI; Anandan ; et al. | 2010-07-29 |
| NK1 antagonists Grant 7,709,641 - Shah , et al. May 4, 2 | 2010-05-04 |
| Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20100087426 - Mergelsberg; Ingrid ; et al. | 2010-04-08 |
| Pyrrolo [3, 2-a] Pyridine Derivatives For Inhibiting Ksp Kinesin Activity App 20100068181 - Paliwal; Sunil ; et al. | 2010-03-18 |
| Novel compounds that are ERK inhibitors App 20090118284 - Cooper; Alan B. ; et al. | 2009-05-07 |
| Fused ring NK.sub.1 antagonists Grant 7,498,438 - Xiao , et al. March 3, 2 | 2009-03-03 |
| Bridged ring NK.sub.1 antagonists Grant 7,354,922 - Xiao , et al. April 8, 2 | 2008-04-08 |
| Novel compounds that are ERK inhibitors App 20070191604 - Cooper; Alan ; et al. | 2007-08-16 |
| Compounds for inhibiting KSP Kinesin activity App 20060281778 - Tagat; Jayaram R. ; et al. | 2006-12-14 |
| Bridged ring NK1 antagonists App 20060258665 - Xiao; Dong ; et al. | 2006-11-16 |
| Compounds for inhibiting KSP kinesin activity App 20060247320 - Tagat; Jayaram R. ; et al. | 2006-11-02 |
| NK1 antagonists Grant 7,122,677 - Reichard , et al. October 17, 2 | 2006-10-17 |
| NK1 antagonists App 20060223804 - Shah; Sapna S. ; et al. | 2006-10-05 |
| NK1 antagonists App 20060199815 - Paliwal; Sunil ; et al. | 2006-09-07 |
| NK.sub.1 antagonists Grant 7,049,320 - Paliwal , et al. May 23, 2 | 2006-05-23 |
| Fused ring NK1 antagonists App 20060040975 - Xiao; Dong ; et al. | 2006-02-23 |
| NK 1 antagonists App 20030158173 - Paliwal, Sunil ; et al. | 2003-08-21 |
| NK1 antagonists App 20030144270 - Reichard, Gregory A. ; et al. | 2003-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 